Archive

ASX Announcements

Date

Headline

2008

26/11/2008	Results of Annual General Meeting	click to view
26/11/2008	Chairman's Address to Shareholders	click to view
24/11/2008	Assoc Prof Mahesh Choolani joins Scientific Advisory Committee	click to view
29/10/2008	OvPlex Media Release	click to view
29/10/2008	OvPlex sales launch in Australia today	click to view
27/10/2008	US Patent Granted for Vascular Permeability	click to view
27/10/2008	Appendix 4C	click to view
24/10/2008	Waiver in respect to proposed issue of convertible notes	click to view
24/10/2008	Notice of Annual General Meeting	click to view
29/09/2008	Launch of OvPlex delayed due to minor technical issues	click to view
17/09/1808	Key Vascular Permeability Patent To Be Granted In The US	click to view
04/09/2008	Appointment of Chief Scientific Officer	click to view
01/09/2008	Annual Report re-released to correct Chairman's biography	click to view
29/08/2008	Appendix 4E and Annual Report to shareholders	click to view
31/07/2008	Appendix 4C - Quarterly	click to view
25/07/2008	Cancellation of lapsed Unlisted Options	click to view
16/07/2008	Change of Director's Interest Notice	click to view
16/07/2008	Non-Renounceable Issue closed	click to view
18/06/2008	HTX Co develop with InSymbiosis therapeutic for lung disease	click to view
19/06/2008	Change in substantial holding N Gatsios	click to view
19/06/2008	Change in substantial holding G Rice	click to view
27/05/2008	Change of Director`s Interest Notice for Nick Gatsios	click to view
26/05/2008	Change in substantial holding from Copulos Group	click to view
26/05/2008	Appendix 3Y for Directors Copulos and Gatsios and Rice	click to view
22/05/2008	Change of Director`s Interest Notice for Prof G E Rice	click to view
21/05/2008	Non-Renounceable Issue allotment as at 19 May 2008	click to view
16/05/2008	Non-Renounceable rights issue under subscriptions	click to view
16/05/2008	Financial Goal for OvPlex Ovarian Cancer Diagnostic Product	click to view
12/05/2008	Change of Directors Interest Notice for Nick Gatsios	click to view
07/05/2008	New Ovarian Cancer Biomarkers to further improve accuracy	click to view
05/05/2008	Change of Directors interest Notice for Nick Gatsios	click to view
05/05/2008	Change of Directors interest Notice for Gregory Rice	click to view
02/05/2008	Closing date Extended for Non-Renounceable issue	click to view
21/04/2008	Appendix 4C Quarterly	click to view
21/04/2008	Appendix 3Y for Nick Gatsios	click to view
21/04/2008	NRRI Prospectus sent to entitled holders today	click to view
21/04/2008	OvPlex test kit packaging ready for Q3 product launch	click to view
14/04/2008	Appendix 3Y for Nick Gatsios	click to view
08/04/2008	Replacement Appendix 4D to correct missing pages	click to view
08/04/2008	Letter to shareholders	click to view
07/04/2008	HealthLinx Limited pro rata non renounceable rights issue	click to view
07/04/2008	Letter sent to option holders today	click to view
03/04/2008	Appendix 3B for pro-rata non renounceable rights issue	click to view
03/04/2008	Rights issue to fund ovarian cancer diagnostic roll out	click to view
12/03/2008	Appendix 3Y for Nick Gatsios	click to view
18/03/2008	Appendix 3X for directors JR Evans and SJ Washer	click to view
18/03/2008	Appendix 3Z for director MG Pennisi	click to view
18/03/2008	Dr Stewart Washer and John Evans appointed Non-Executive Directors	click to view
28/02/2008	Appendix 3Y for Nick Gatsios	click to view
27/02/2008	Half Yearly Report and Accounts Appendix 4D	click to view
21/02/2008	Accuracy of early stage ovarian cancer diagnostic confirmed	click to view
21/02/2008	Professor Gregory Rice appointed Chairman of HealthLinx	click to view
06/02/2008	Response to ASX 4C Query	click to view
24/01/2008	Appendix 4C - quarterly	click to view
14/01/2008	App 3B unlisted options and App 3Ys	click to view

Date

Headline

2007

18/12/2007	Appendix 3Z for Graham Watman	click to view
17/12/2007	Appendix 3Y for Nick Gatsios	click to view
17/12/2007	HealthLinx announces retirement of Graham Watman	click to view
26/11/2007	HealthLinx In-Licenses New Technology to Develop 2nd Generation Ovarian Cancer Diagnostic	click to view
21/11/2007	Consolidation of shares completed	click to view
15/11/2007	HealthLinx completes OvPlex Phase II Biomarker Trial	click to view
15/11/2007	Trading Halt	click to view
08/11/2007	Results of Meeting	click to view
08/11/2007	Shareholders approve share consolidation	click to view
07/11/2007	ASX Circular: Share Consolidation	click to view
26/10/2007	Appendix 4C - quarterly report to 30 September 2007	click to view
18/10/2007	Change to key dates for proposed share consolidation	click to view
18/10/2007	Correction of incorrect date	click to view
17/10/2007	HealthLinx to establish new drug development company	click to view
08/10/2007	Notice of Annual General Meeting	click to view
08/10/2007	HealthLinx Announces Share Consolidation	click to view
02/10/2007	Appendix 3Y for Nick Gatsios	click to view
02/10/2007	Appendix 3Y for Stephen Copulos	click to view
27/09/2007	Annual Report To Shareholders 2007	click to view
18/09/2007	Independent Audit Report	click to view
12/09/2007	Copulos Group - Appendix 3Y	click to view
12/09/2007	HealthLinx Expands Scientific Advisory Committee	click to view
29/08/2007	Appendix 4E-Preliminary Final Report	click to view
20/08/2007	Movement in Unlisted Options & Appendix 3B	click to view
16/08/2007	Ovarian Cancer Diagnostic Phase II Biomarker Trial Begins	click to view
30/07/2007	Collaboration with University of Virginia for ARDS Syndrome Treatment	click to view
26/07/2007	Appendix 4C - Quarterly	click to view
29/06/2007	Special Placement Completed & S708A Notice	click to view
26/06/2007	Second Collaboration Using Cryptomics Platform	click to view
19/06/2007	Initial Director's Interest Notice	click to view
19/06/2007	Appointment of Director	click to view
19/06/2007	Change of Director's Interest Notice	click to view
19/06/2007	Appendix 3B	click to view
30/05/2007	Collaboration with Warrnambool Cheese & Butter CRC	click to view
18/05/2007	Prof. Greg Rice Appointed General Manager Science & Operations	click to view
08/05/2007	Change In Substantial Holding	click to view
07/05/2007	Section 708A(5) Notice 1	click to view
07/05/2007	Appendix 3B - Placement	click to view
07/05/2007	Placement of 49.4m Ordinary Shares	click to view
27/04/2007	Becoming A Substantial Holder	click to view
18/04/2007	Commitments Test Entity - 3rd Quarter Report	click to view
02/04/2007	Appendix 3B	click to view
29/03/2007	Change of Director's Interest Notice	click to view
20/03/2007	Final Prototype In Protein Depletion Technology Program	click to view
02/03/2007	Change of Director's Interest Notice x3	click to view
01/03/2007	Notice of Expiry of Listed Options 30 March 2007	click to view
28/02/2007	Half Yearly Report & Half Year Accounts	click to view
26/02/2007	Validation Of Vascular Permeability Program	click to view
14/02/2007	HealthLinx Ltd Announces Completion of Rights Issue	click to view
14/02/2007	S708A Notice for rights issue shortfall shares issued today	click to view
14/02/2007	Ceasing To Be A Substantial Holder	click to view
05/02/2007	Allotment of Rights Issue Ordinary Shares	click to view
01/02/2007	Voluntary Restrictions Expire 14 February 2007	click to view
30/01/2007	Commitments Test Entity - 2nd Quarter Report	click to view
09/01/2007	Dispatch of Prospectus to Share Holders	click to view
09/01/2007	Letter to Option Holders	click to view
09/01/2007	Letter to Shareholders	click to view

Date

Headline

2006

21/12/2006	Disclosure Document	click to view
21/12/2006	HealthLinx & Monash University Expand Collaboration	click to view
06/12/2006	Appendix 3B	click to view
06/12/2006	Proposed Non-Renounceable Rights Issue	click to view
21/11/2006	Bruker & HealthLinx Expand Biomarker Collaboration	click to view
20/11/2006	Results of AGM	click to view
17/11/2006	AGM Chairman's Presentation	click to view
16/11/2006	Agreement with MIMR at Monash University	click to view
15/11/2006	Provisional Patent Lodgement	click to view
20/10/2006	Commitments Test Entity - 1st Quarter Report	click to view
18/10/2006	Chairman's Letter & Notice of AGM	click to view
10/10/2006	Change of Director's Interest Notice x5	click to view
10/10/2006	Appendix 3B: Unquoted Options Issued Re Employment Agreement	click to view
10/10/2006	Expiry of Unlisted Options	click to view
29/09/2006	Annual Report 2006	click to view
12/09/2006	Preliminary Final Report	click to view
11/08/2006	Licence Agreement with University of Virginia	click to view
31/07/2006	Appendix 3B	click to view
31/07/2006	Agreement with ARL Pathology	click to view
27/07/2006	Commitments Test Entity - 4th Quarter Report	click to view
18/07/2006	Change of Director's Interest Notice	click to view
19/06/2006	Change of Director's Interest Notice	click to view
06/06/2006	Allotment & Quotation of Options	click to view
01/06/2006	Completes appointments to Scientific Advisory Committee	click to view
15/05/2006	Lapsing of Unlisted Options	click to view
12/05/2006	Recruitment of 3000 Women for Ovarian Diagnostic Trial	click to view
04/05/2006	Appendix 3B for new options issue and quotation	click to view
03/05/2006	Disclosure Document for Options Issue	click to view
01/05/2006	Reinstatement to Official Quotation	click to view
01/05/2006	Commitments Test Entity - 3rd Quarter Report	click to view
01/05/2006	Suspension from Official Quotation	click to view
24/04/2006	HealthLinx correction of unlisted option numbers	click to view
07/04/2006	Proposed Option Issue	click to view
03/04/2006	Ethics approval & milestones	click to view
29/03/2006	Scientific Advisory Committee Appointments	click to view
16/03/2006	Lapsing of unlisted options	click to view
16/03/2006	Completion of Merger with Cryptome Pharmaceuticals Ltd	click to view

Announcements released as Cryptome Pharmaceuticals

Date

Headline

Pages

15/03/2006	Half Yearly Report & Half Year Accounts	33	click to view
02/03/2006	Change in substantial holding from CBA	4	click to view
01/03/2006	Ceasing to be a substantial holder x 2	2	click to view
28/02/2006	Cryptome Managing Directors Remuneration	1	click to view
23/02/2006	Becoming a substantial holder	88	click to view
21/02/2006	Becoming a substantial holder x4	9	click to view
17/02/2006	Replacement Appendix 3B	10	click to view
17/02/2006	Appendix 3B & Top20/Distribution Schedule	11	click to view
17/02/2006	Final Director's Interest Notice x4	8	click to view
17/02/2006	Initial Director's Interest Notice x 4	8	click to view
17/02/2006	Completes Acquisition of HealthLinx/Capital Raising	3	click to view
14/02/2006	Notice under Section 708A	1	click to view
10/02/2006	Cryptome results of General Meeting held today	3	click to view
30/01/2006	Commitments Test Entity - Second Quarter Report	5	click to view
24/01/2006	Appendix 3B	8	click to view
10/01/2006	Lapsing of Unlisted Options	1	click to view
09/01/2006	General Meeting Notice posted to members today	90	click to view